The dynamic regulation of actin polymerization plays crucial roles in cell morphology and endocytosis. The mechanistic details of these processes and the proteins involved are not fully understood, especially in neurons. PICK1 is a PDZ-BARdomain protein involved in regulated AMPA receptor (AMPAR) endocytosis in neurons. Here, we demonstrate that PICK1 binds filamentous (F)-actin and the actin-nucleating Arp2/3 complex, and potently inhibits Arp2/3-mediated actin polymerization. RNA interference (RNAi) knockdown of PICK1 in neurons induces a reorganization of the actin cytoskeleton resulting in aberrant cell morphology. Wild-type PICK1 rescues this phenotype, but a mutant PICK1, PICK1
The dynamic actin cytoskeleton plays multiple roles in eukaryotic cells to regulate cell morphology, cell motility and vesicle trafficking by exerting mechanical forces that alter the shape of the plasma membrane. The Arp2/3 complex is the major catalyst for the formation of branched actin networks that mediate changes in membrane geometry. Proteins such as N-WASP, WAVE and cortactin bind and activate the Arp2/3 complex so that changes in cell morphology or vesicle trafficking occur at appropriate times and subcellular locations [1] [2] [3] . Regulation of the actin cytoskeleton is crucial for neuronal morphogenesis 1, 4, 5 . Recent reports have suggested a role for the Arp2/3 activator N-WASP in neurite elongation and branching in neuronal development 6, 7 ; however, negative regulators of the Arp2/3 complex in these processes have not yet been identified. A role for Arp2/3-mediated actin dynamics in the regulation of endocytosis in mammalian cell lines is becoming increasingly well established. Localized alterations in actin turnover are proposed to provide mechanical forces that contribute to plasma membrane curvature, vesicle scission and propulsion of nascent vesicles away from the membrane 2, [8] [9] [10] . The specific molecular mechanisms for regulating actin to control endocytosis in neurons are unknown. Dendritic spines, the sites of excitatory synapses in neurons, are particularly enriched in F-actin [11] [12] [13] , which is extremely dynamic, rapidly cycling between globular (G)-actin and F-actin 14 . As designated endocytic sites are found in dendritic spines 15, 16 , it seems likely that the densely packed, dynamic actin filaments influence endocytosis.
PICK1 is a PDZ-and BAR-domain-containing protein that binds to a number of membrane proteins, including AMPAR subunits GluR2/3. This interaction is required for AMPAR internalization in response to Ca 2+ influx via NMDAR activation in hippocampal neurons [17] [18] [19] [20] [21] . This is a major mechanism that underlies the reduction in synaptic strength in long-term depression (LTD), which is thought to play a role in learning and memory 20, 21 . The precise molecular mechanisms for the action of PICK1 in receptor endocytosis are unclear.
Here, we demonstrate that PICK1 is an inhibitor of Arp2/3-mediated actin assembly. This regulation is required for the organization of the actin cytoskeleton to establish appropriate neuronal morphology. Furthermore, we demonstrate that inhibition of Arp2/3 activity by PICK1 is required for NMDA-induced AMPAR endocytosis.
RESULTS

PICK1 binds actin
As certain proteins with BAR-like domains are involved in actin regulation [22] [23] [24] , we asked whether PICK1 interacts with actin. Coimmunoprecipitations from neuronal extracts demonstrate the presence of a PICK1-actin-GluR2 complex (Fig. 1a) . Actin-binding proteins may associate with G-actin or F-actin; therefore, we analysed which form binds to PICK1. In pulldown assays, GST-PICK1 does not bind G-actin (see Supplementary Information, Fig. S1 ). To investigate F-actin binding, actin sedimentation assays were performed using actin filaments polymerized in vitro. As the concentration of actin increased, GST-PICK1 was enriched in the F-actin pellet (Fig. 1b) . GST-PICK1 bound F-actin with a K D of ~0.3 µM. To identify the actin-binding region of PICK1, truncation mutants of GST-PICK1 were analysed. The BAR domain was necessary and sufficient for binding F-actin (Fig. 1c) . In fact, the isolated BAR domain (b) PICK1 binds directly to F-actin. Cosedimentation assay using 0-5 µM rabbit muscle actin and 100 nM GST-PICK1 was resolved by SDS-PAGE followed by Coomassie staining. S, supernatants; P, pellets. The arrowhead indicates actin-degradation product. Quantification of the percentage of PICK1 bound to F-actin as a function of actin concentration is also shown. The error bars represent mean ± s.e.m. (n = 4). (c) PICK1 binds F-actin via its BAR domain. Cosedimentation assay using 2.5 µM rabbit muscle actin and 100 nM GST-PICK1 or truncation mutants, resolved by SDS-PAGE followed by Coomassie staining. The arrowheads indicate actin and actin-degradation product. Quantification of the percentage of wild-type PICK1 and PICK1 mutants bound to F-actin is also shown. The single asterisk indicates P <0.05 and the triple asterisk indicates P <0.001. The error bars represent mean ± s. e.m. (n = 5). (d) Sequence alignment of the C-terminus of PICK1 with known activators of the Arp2/3 complex. Conserved tryptophan residues are shown in green. Acidic amino acids are shown in red. (e) GST-PICK1 binds directly to purified Arp2/3 complex. Immobilized GST and GST-PICK1 were incubated with 10 nM purified Arp2/3. Bound proteins were detected by immunoblotting (p34 Arc is a subunit of the Arp2/3 complex). (f) PICK1 and GluR2 interact with the Arp2/3 complex in neurons. Extracts from cultured cortical neurons were immunoprecipitated with anti-p34 antibodies or control IgG, and bound proteins detected by immunoblotting. (g) PICK1 and the Arp2/3 complex are similarly associated with the postsynaptic density (PSD). PSD fractions (PSD I, II and III) were prepared by extraction of synaptosomes (Syn) once (I) or twice (II) with Triton X-100 or with Triton X-100 and SDS (III). Proteins were detected by immunoblotting. (h) PICK1 colocalizes with Arp2/3 at synapses. Hippocampal neurons were stained for PICK1 (red), Arp2/3 subunit p34 (green) and the synaptic marker PSD-95 (blue). Colocalization is white in the merged image. The scale bars represent 10 µm in the upper panels and 5 µm in the lower panels.
bound to actin more efficiently than full-length PICK1, suggesting that either the PDZ domain or the carboxy-terminal region inhibited the interaction.
PICK1 binds the Arp2/3 complex PICK1 contains an acidic region (D 380 GEDEEEEEED 390 ) and a tryptophan residue (Trp 413), resembling Arp2/3 activators (Fig. 1d) . A pulldown assay using GST-PICK1 and purified Arp2/3 complex indicated that these proteins can interact directly (Fig. 1e) , and coimmunoprecipitations from neuronal extracts demonstrated an interaction between Arp2/3, PICK1 and GluR2 in native tissue (Fig. 1f) . PICK1 is known to be loosely associated with the postsynaptic density (PSD) 25 . Both PICK1 and Arp2/3 were found in PSD fractions I and II purified from brain synaptosomes (Fig. 1g) . Furthermore, PICK1 and Arp2/3 colocalized at PSD-95 immunopositive synaptic sites in a subset of hippocampal neurons (Fig. 1h) .
PICK1 inhibits Arp2/3-mediated actin polymerization
In vitro pyrene-labelled actin polymerization assays were used to investigate regulation of the Arp2/3 complex by PICK1. PICK1 did not stimulate Arp2/3-mediated actin polymerization, in contrast to the N-WASP VCA domain 26 ( Fig. 2a) . Surprisingly, PICK1 reduced the rate of VCA-stimulated Arp2/3-mediated actin assembly in a dosedependent manner (Fig. 2b ). PICK1-Flag purified from neurons had similar inhibitory activity ( Fig. 2c ; see Supplementary Information, Fig. S1 ). Coimmunoprecipitation from transfected COS cells showed that PICK1 and N-WASP VCA did not interact (see Supplementary  Information, Fig. S1 ), indicating that PICK1 is not inhibiting VCA by direct interaction. Therefore, we asked whether PICK1 could compete with VCA for binding to the Arp2/3 complex. When PICK1 was present, VCA was displaced from the Arp2/3 complex (Fig. 2d) , suggesting that PICK1 and VCA compete for the same binding site (a) PICK1 does not activate the Arp2/3 complex. In vitro polymerization of pyrene-labelled actin (2.5 µM) was monitored using time-based fluorimetry. Additional components were: 25 nM Arp2/3 complex, 100 nM GST-VCA, 1 µM His 6 -PICK1. (b) PICK1 inhibits VCA and Arp2/3-stimulated actin polymerization in a dose-dependent manner. Various concentrations of His 6 -PICK1 (0.1-1 µM) were added to 2.5 µM pyrene-actin, 25 nM Arp2/3 and 100 nM GST-VCA in an in vitro polymerization assay. (c) PICK1 purified from neurons inhibits VCA and Arp2/3-stimulated actin polymerization. High-density cortical neurons were transduced with PICK1-Flag-IRES-EGFP Sindbis virus. PICK1-Flag was purified by immunoprecipitation (see Methods). Proteins eluted with the flag peptide were added to pyrene-actin, Arp2/3 complex and GST-VCA in an in vitro polymerization assay. Eluates of immunoprecipitations from non-transduced neurons were used as control.
(d) PICK1 and VCA compete for binding to the Arp2/3 complex. Purified Arp2/3 was immunoprecipitated with anti-p34 antibody. Immunocomplexes were incubated with 100 nM purified GST-VCA with or without 500 nM His 6 -PICK1. After washing of beads, proteins were detected by immunoblotting. Representative western blots and quantification of relative GST-VCA binding to Arp2/3 in the absence or presence of PICK1 are shown. The error bars represent mean ± s.e.m. (n =3). The double asterisk indicates P < 0.01 (e) PICK1 inhibits the Arp2/3 complex directly. Polymerization of 5 µM pyrene-labelled actin in the presence of 100 nM Arp2/3 was inhibited by 400 nM His 6 -PICK1.
nature cell biology volume 10 | number 3 | mArCH 2008 2 6 1 on Arp2/3. A high concentration of Arp2/3 complex has some actinnucleating activity, even in the absence of VCA 27 . PICK1 inhibited actin assembly stimulated by 100 nM Arp2/3 complex without VCA (Fig. 2e) , suggesting that PICK1 can directly disrupt the nucleating activity of Arp2/3.
These data demonstrate that PICK1 reduces the rate of actin assembly by two distinct mechanisms: first, by disrupting VCA-Arp2/3 interactions and second, by inhibiting the nucleating activity of Arp2/3 directly.
Trp 413 is required for Arp2/3 binding to PICK1 and inhibition of actin polymerization We analysed the PICK1 sequence requirements for Arp2/3 binding using PICK1 truncation mutants. The minimal region for Arp2/3 interaction comprised amino acids 280-416 (∆280; Fig. 3a ). The C-terminal tryptophan in full-length PICK1 was mutated to alanine (W413A). This single amino-acid substitution eliminated Arp2/3 binding (Fig. 3b) . As expected, GluR2 C-terminus bound equally well to both PICK1 W413A and wild-type PICK1 (Fig. 3b) . Additional PICK1 binding partners were also unaffected by this mutation (see Supplementary Information,  Fig. S1 ). Consistent with an inability to bind Arp2/3, PICK1
W413A did not compete with VCA domain for Arp2/3 binding (Fig. 3c) . In actin polymerization assays PICK1 W413A had no effect on VCA-stimulated Arp2/3-mediated actin assembly (Fig. 3d) , demonstrating that Arp2/3 binding is an absolute requirement for the inhibitory effect of PICK1 on actin polymerization.
Lys 251 and Lys 252 are required for actin binding and inhibition of actin polymerization PICK1 was shown to bind actin via the BAR domain (Fig. 1) . To investigate a precise actin-binding motif, a double lysine motif (KK251,252) that is similar to the F-actin binding motif in pan1p was analysed 28 . Mutating Lys 251 and Lys 252 in GST-PICK1 BAR domain to glutamate (KK251,252EE) abolished F-actin binding (Fig. 3e) . In actin polymerization assays, PICK1 KK251,252EE had no effect on VCA-stimulated Arp2/3-mediated actin assembly (Fig. 3f) , demonstrating that actin binding is required for the inhibition of actin polymerization by PICK1. In agreement with previous studies 29, 30 , the KK251,252EE mutation also inhibited PICK1-lipid vesicle interactions; however, Arp2/3 binding was unaffected by this mutation (see Supplementary Information, Fig. S1 ).
Regulation of Arp2/3 complex by PICK1 is critical for maintaining the neuronal actin cytoskeleton
To analyse the role of PICK1 in regulating the neuronal actin cytoskeleton, short hairpin RNA (shRNA) constructs were designed to reduce PICK1 expression in hippocampal neurons. The constructs coexpressed mCherry fluorescent protein under the control of the neuronal CamKII promoter. PICK1 shRNA resulted in efficient PICK1 knockdown in transfected COS cells (see Supplementary Information, Fig. S2 ), and in hippocampal neurons (Fig. 4a ). In addition, neurons transfected with PICK1 shRNA at 9-10 DIV showed a dramatic change in morphology 5 days later (Fig. 4a) . Neurons transfected at 13-14 DIV were more resistant to these morphological changes (Fig. 5 ). Sholl analysis of neurons transfected at 10 DIV revealed a significant increase in the number of processes close to the cell body (at 10 and 20 µm radii) and significantly fewer distal processes (at 80-120 µm radii) compared with controls ( Fig. 4b) . CamKII staining confirmed that all transfected cells were indeed neurons (see Supplementary Information, Fig. S2 ). The subcellular localizations of GluR2 and Arp2/3 were altered in PICK1 shRNA-transfected neurons (see Supplementary Information, Fig. S2 ). Cotransfection of an shRNA-resistant wild-type PICK1 construct carrying silent mutations rescued neuronal morphology, confiming that the RNAi effect was indeed a direct result of PICK1 knockdown. In striking contrast, PICK1
W413A did not rescue shRNA-induced changes (Fig. 4c,  d ). These experiments suggest that inhibition of Arp2/3 by PICK1 is required for correct neuronal morphology, and that the morphological changes that occur after PICK1 knockdown are due to over activity of the Arp2/3 complex. To investigate this further, the CA domain of N-WASP was used to inhibit Arp2/3 (ref. 31) in neurons with reduced PICK1 levels. Expression of N-WASP-CA reduced the aberrant proximal branching, but did not rescue the effects on distal processes (Fig. 4c,  d ). Interestingly, cotransfection of PICK1 shRNA with shRNA-resistant PICK1 KK251,252EE , which does not bind F-actin, had an intermediate effect, and only partially rescued the aberrant proximal branching. Overexpressing each of these PICK1 constructs on a control mCherry background had no significant effect on gross neuronal morphology (see Supplementary Information, Fig. S3 ). To directly analyse the effect of PICK1 on the neuronal actin cytoskeleton, fluorophore-conjugated phalloidin was used to visualize F-actin in shRNA-transfected neurons. In neurons transfected with control plasmids, F-actin was found to be concentrated in dendritic spines and the cell periphery, as previously demonstrated [11] [12] [13] . Five days after transfection with PICK1 shRNA, Factin had an altered distribution, correlating with the aberrant morphology (Fig. 4e) . Furthermore, the total phalloidin staining was significantly higher, providing additional evidence that PICK1 functions as an inhibitor of actin polymerization in neurons. Cotransfection with shRNAresistant wild-type PICK1, but not PICK1 W413A , rescued the RNAi effects on the actin cytoskeleton (Fig. 4e) .
To investigate whether the increased branching close to the cell body represents bona fide dendritic branching, anti-MAP2 immunocytochemistry was performed on control and PICK1 shRNA-transfected neurons. Sholl analysis of the MAP2 immunofluorescence demonstrated that there was an increase in proximal dendritic branching in PICK1 shRNA-transfected cells compared with controls (see Supplementary  Information, Fig. S4 ). Qualitative analysis indicated that not all processes induced by PICK1 knockdown were MAP2-positive (see Supplementary  Information, Fig. S4 ), suggesting that not all aberrant actin-based protrusions result in the formation of a dendrite.
Inhibition of Arp2/3-mediated actin polymerization by PICK1 is required for NMDA-induced AMPAR endocytosis
As PICK1 is crucial for regulated AMPAR endocytosis [17] [18] [19] [20] [21] 29, 32 , we asked whether the inhibition of actin polymerization via PICK1-Arp2/3 interactions provides a driving force for receptor trafficking. Given that aberrant neuronal morphology might in itself affect trafficking events, an alternative approach was used to study AMPAR trafficking. Neurons transfected at 13-14 DIV were more resistant to morphological changes compared with those transfected at 9-10 DIV (Fig. 5a) . A 'chemical LTD' protocol was used, whereby NMDARs are activated by bath application of NMDA to induce AMPAR internalization 19, 29, 33 . Antibody-feeding immunocytochemistry was performed at 18 DIV on cultured hippocampal neurons transfected at 13 DIV to quantify the degree of internalization of GluR2 occurring in response to NMDA treatment. Control neurons showed a twofold increase in GluR2 endocytosis in response to NMDA, which was completely blocked in PICK1 shRNA-transfected neurons (Fig. 5b ). Neurons cotransfected with PICK1 shRNA and shRNA-resistant wild-type PICK1 exhibited restored NMDA-induced AMPAR endocytosis. However, in neurons cotransfected with PICK1 shRNA and PICK1
W413A
, NMDA-induced AMPAR endocytosis was completely abolished (Fig. 5c) .
To provide further evidence that PICK-Arp2/3 interactions are required for regulated AMPAR internalization, we also employed a dominant-negative approach. As demonstrated before, overexpression of wild-type PICK1 enhanced NMDA-induced AMPAR endocytosis compared with EGFP-expressing controls 19 . In stark contrast, PICK1
W413A blocked NMDA-induced internalization of GluR2-containing AMPARs (Fig. 6a) . Overexpression of neither protein influenced transferrin receptor internalization (see Supplementary Information,  Fig. S5 ). As NMDA-induced AMPAR endocytosis was blocked by a PICK1 mutant that was unable to inhibit actin polymerization, we asked whether this block could be reversed by pharmacological inhibition W413A blocks trafficking because of an inability to inhibit actin polymerization (Fig. 6b) . Note that this level of latrunculin treatment did not alter neuronal morphology, consistent with a previous report 34 . To provide additional evidence that inhibition of the Arp2/3 complex is required for AMPAR internalization, AMPAR internalization was assayed in neurons expressing the N-WASP CA domain, which inhibits the endogenous Arp2/3 complex 31 . Inhibition of actin polymerization by CA domain expression resulted in increased basal AMPAR internalization, which occluded the NMDA-induced increase in endocytosis (Fig. 6c) .
We also performed internalization assays in COS cells expressing GluR2-Myc and wild-type PICK1 or PICK1 W413A . Wild-type PICK1 mediates robust GluR2 internalization 19 . In contrast, GluR2 endocytosis in PICK1 W413A -expressing cells was similar to levels in the absence of PICK1 (see Supplementary Information, Fig. S5 ), indicating that interactions with Arp2/3 are required for PICK1-mediated GluR2 endocytosis. Interestingly, latrunculin treatment had a different effect in COS cells compared with neurons, and resulted in reduced levels of GluR2 endocytosis in both wild-type and PICK1 W413A -transfected cells. This suggests differences in actin-based endocytic mechanisms between neurons and COS cells.
Taken together, these data demonstrate that the inhibition of Arp2/3-mediated actin polymerization by PICK1 is required for the NMDAinduced endocytosis of GluR2-containing AMPARs in neurons.
Interaction with GluR2 C-terminus enhances inhibition of Arp2/3 complex by PICK1
The dual role for PICK1-Arp2/3 interactions in AMPAR trafficking and cell morphology suggests that PICK1 may tonically inhibit the Arp2/3 complex, yet provide an enhanced, localized and transient inhibition to drive AMPAR endocytosis. Therefore, we investigated the possibility that the inhibition of actin polymerization by PICK1 is regulated by interacting with GluR2. The PDZ domain forms an intramolecular interaction with the BAR domain, inhibiting non-PDZ interactions with additional proteins. This conformation is disrupted by binding of a PDZ ligand, exposing the BAR domain/C-terminal region to additional interactors 29 (also see Supplementary Information, Fig. S6 ). As actin and Arp2/3 complex bind non-PDZ regions of PICK1, we asked whether the GluR2 C-terminus (R2C) could modulate F-actin and Arp2/3 binding by altering the conformation of PICK1. Addition of R2C resulted in significant increases in PICK1-actin and PICK1-Arp2/3 interactions (Fig. 7a, b) . These results suggest that GluR2 binding might enhance the inhibitory effect of PICK1 on Arp2/3-mediated actin assembly. As predicted, R2C dramatically enhanced the inhibition of actin polymerization by PICK1, resulting in nearly complete blockade of actin assembly (Fig. 7c) .
As the proposed mechanism for this allosteric modulation is displacement of the PDZ domain from the BAR domain, we analysed the binding of F-actin and Arp2/3 to PICK1 with the PDZ domain deleted (PICK1 ∆105 ). Arp2/3 binding to PICK1 was enhanced by PDZ deletion (Fig. 7d) . Consistent with this, we demonstrated that binding to F-actin was also enhanced by PDZ deletion (Fig. 1e) . Furthermore, PICK1 ∆105 competed with VCA for Arp2/3 binding much more efficiently than wild-type PICK1 (Fig. 7e) . Adding purified PDZ domain (PICK1 135∆ ) to PICK1
∆105 inhibited binding to both actin and Arp2/3, confirming an allosterically regulated interaction with PICK1 (Fig. 7f, g ). Consistent with these observations, PDZ domain deletion potentiated the inhibition of actin polymerization by PICK1 (Fig. 7h) . Adding the free PDZ domain (PICK1
135∆
) to this reaction reduced the inhibition of actin assembly by PICK1 ∆105 (Fig. 7h) , confirming that the intramolecular interaction between the PDZ domain and the BAR domain plays a crucial role in controlling the inhibition of actin polymerization by PICK1. We then investigated the effect of PDZ-deletion of PICK1 in hippocampal neurons. PICK1
∆105 expression reduced branching in proximal dendrites in PICK1 shRNA treated neurons to a greater extent than wild-type PICK1 (Fig. 7i) , suggesting that PDZ deletion enhances the influence of PICK1 on the actin cytoskeleton in neurons. PICK1 135∆ did not rescue neuronal morphology, presumably because this protein does not bind actin or Arp2/3.
These data show that the PICK1-R2C complex has a greater effect on reducing actin assembly compared with PICK1 alone, providing a mechanism for regulating PICK1 so that it is less active when the PDZ domains are unoccupied, and maximally active when bound to AMPARs.
DISCUSSION
Here, we describe a molecular mechanism for regulating neuronal actin dynamics by PICK1. PICK1 binds F-actin and the Arp2/3 complex, and inhibits Arp2/3-mediated actin assembly activated by the N-WASP VCA domain. This mechanism has two distinct roles in neuronal function; first, it is critical for development of neuronal morphology, and second, it is required for stimulated AMPAR endocytosis.
Our data demonstrate that constitutive inhibition of Arp2/3-mediated actin polymerization by PICK1 is required to establish appropriate neuronal morphology. One of the characteristics of neurons with reduced PICK1 expression is an increase in projections from the cell body and proximal dendrites. This effect is reversed by inhibition of Arp2/3 activity, confirming that PICK1 prevents aberrant actin-based branching by suppressing Arp2/3 activity. A second morphological effect of PICK1 knockdown is a reduction in neurite length. This is consistent with previous reports demonstrating a requirement for Arp2/3 inhibition in neurite elongation 31 . However, inhibition of Arp2/3 activity by N-WASP-CA does not rescue neurite length, suggesting that alternative specific properties of PICK1 protein are involved in dendrite outgrowth. It has been shown that PICK1 is involved in regulation of growth cone function via a PDZ domain interaction with the netrin-1 receptor UNC5 (ref. 35) . This is consistent with our observation that PDZ-deleted PICK1 does not rescue the distal effects of PICK1 knockdown as efficiently as wild-type PICK1. The morphological effects of PICK1 knockdown seem to be restricted to immature neurons, suggesting that following a certain developmental period, PICK1 is less critical for maintaining appropriate gross morphology of the dendritic arborization. Further studies are required to investigate the precise role of PICK1 in neuronal development.
Recent studies have defined a role for actin dynamics in endocytosis in mammalian cell lines 2, [8] [9] [10] . It has been proposed that actin polymerization occurs around the nascent endocytic vesicle to provide mechanical forces for late stages of invagination and vesicle scission. Actin assembly occurring early and directly at the nascent coated pit may create forces to oppose membrane invagination 2 (Fig. 8) . Therefore, the initial invagination of the plasma membrane would require a phase of reduced F-actin, which may be followed by a highly localized, restricted burst of actin polymerization around the neck of the coated pit to drive scission and subsequent propulsion away from the plasma membrane 2, 10 . In fact, actin assembly at clathrin-coated pits in fibroblasts has been observed as a transient late event, following clathrin and dynamin recruitment by several seconds, suggesting that the early induction of membrane curvature occurs under conditions of low F-actin 36, 37 . We propose that PICK1 functions to inhibit actin assembly at endocytic sites until membrane invagination has been initiated (Fig. 8 ).
Although consistent with previous studies 34 , which demonstrated that depolymerization is the important shift in actin dynamics to trigger AMPAR endocytosis, two of our results were surprising to us: the reversal of the PICK1 W413A -mediated block of AMPAR endocytosis by the actin depolymerizing drug latrunculin and the enhanced basal AMPAR endocytosis following Arp2/3 inhibition by N-WASP CA domain. Both suggest that assembly of actin filaments may be less important for AMPAR internalization than proposed for endocytic events in non-neuronal cells, and that the high density of F-actin in dendritic spines may be the dominant factor that constrains AMPAR trafficking. Although the CA domain enhances basal trafficking that occludes NMDA-induced internalization, overexpression of wild-type PICK1 has no impact on basal trafficking, but instead enhances the NMDA effect. This difference between the two Arp2/3 inhibitors is likely to reflect the Ca 2+ -sensitivity of PICK1. In the absence of NMDAR activation, PICK1 binds weakly to GluR2 and therefore does not influence AMPAR trafficking 19 . Presumably PICK1 only inhibits Arp2/3 strongly enough to drive AMPAR internalization when bound to GluR2. In contrast, the CA domain inhibits Arp2/3 potently and ubiquitously enough to influence receptor trafficking, with no dependence on Ca 2+ signals or additional protein interactions.
As the BAR domain binds lipid membranes 30 and may be involved in generating membrane curvature 22, 38, 39 , inhibition of Arp2/3-mediated actin polymerization by PICK1 could contribute to membrane bending by reducing membrane tension and the rigidity of the cortical actinplasma membrane module 39 . The KK251,252 motif that we identify as the actin-binding site on PICK1 has previously been implicated in mediating the binding of the BAR domain to phospholipid membranes 29, 30 , an observation that we confirm in this study. This strengthens the hypothesis that membrane bending is linked to actin-based processes via PICK1. Other proteins with BAR-like domains also have lysine-based motifs that mediate interactions with both phospholipids and F-actin 40 .
The dual role of the PICK1-Arp2/3 interaction in both trafficking and in the constitutive maintenance of the actin cytoskeleton may depend upon the PDZ-regulated allosteric switch. Under basal conditions, PICK1 PDZ domains may be unoccupied, resulting in a low, tonic level of Arp2/3 regulation that contributes to the development of neuronal morphology. NMDAR-mediated Ca 2+ influx stimulates the interaction of GluR2 with the PICK1 PDZ domain 19 , resulting in enhanced interactions with F-actin and with Arp2/3 and, thus, enhanced inhibition of actin polymerization specifically at the site of AMPAR endocytosis (see Fig. 8 ). This provides a mechanism for ensuring a tight temporal and spatial synchronization of cargo recruitment and membrane invagination.
We have identified PICK1 as a novel regulator of the actin cytoskeleton in neurons. This work provides important mechanistic information about the modulation of the neuronal cytoskeleton and highlights PICK1 as a key molecule linking the fundamental cellular processes of cytoskeletal remodelling and protein traffic.
METHODS
Plasmids and plasmid construction. His 6 proteins were expressed from pET28 (Novagen), GST-fusions from pGEX4T-1 (Pharmacia). For COS cells, wild-type and PICK1
W413A were expressed from pcDNA3.1. For Sindbis viruses, wild-type and PICK1
W413A were ligated into pIRES-EGFP, then into pSinRep(nsP2S). shRNA and mCherry reporter were expressed from a modified pFIV (System Biosciences). mCherry was driven by the CamKII promoter, shRNA by the H1 RNA pol III promoter. The PICK1 shRNA sequence was as follows: 5´-AAAG TACTATAATGACTGCTATTTCAAGAGAATAGCAGTCATTATAGTAC-3´.
The control construct did not contain shRNA. Wild-type PICK1, PICK1W413A, PICK1KK251,252EE, PICK1∆105 and PICK1∆135 and N-WASP CA domain expressed from pIRES-EGFP were used for neuronal transfections. For rescue experiments, wild-type PICK1, PICK1W413A and PICK1KK251,252EE with silent mutations: TAc AAc GAt TGt TAc GCg (mutations in lower case) were expressed from pIRES-EGFP.
Preparation of recombinant proteins. His 6 -and GST-fusions were expressed and purified as described 41 , except that His 6 -fusions were eluted in 10 mM at Tris pH 7.5, 60 mM NaCl, 2 mM DTT, 400 mM imidazole. PICK1-Flag was expressed in cortical neuronal cultures using Sindbis virus 19 . Protein was immunoprecipitated using anti-Flag antibody-conjugated agarose beads. After washing, proteins were eluted from the beads with 1 mg ml -1 Flag peptide.
Antibodies. The antibodies used were as follows: anti-p34 (Arp2/3 complex; BD biosciences); anti-β-actin (Sigma); anti-pan-actin (Sigma); anti-FLAG (M2, Sigma); anti-Myc (Santa Cruz); anti-PICK1 (rabbit, ABR; goat, Santa Cruz; mouse NeuroMab); anti-PSD95 (NeuroMab); anti-GluR2 (Chemicon, Zymed), anti-GST (Novagen); anti-MAP2 (Sigma); anti-N-WASP (Santa Cruz).
Buffers. Lysis buffer: 25 mM HEPES at pH 7.5, 125 mM NaCl, 0.5% TX-100, protease inhibitor cocktail (Roche). Coimmunoprecipitation from neuronal cultures. Coimmunoprecipitations were performed essentially as previously described 19 . Extracts of 12-15 DIV hippocampal cultures were prepared in lysis buffer. Anti-PICK, anti-p34 or control IgG (3 µg) was used for immunoprecipitation.
GST pulldown assays. For Arp2/3 binding experiments, 5 µg of GST or GST-PICK1 was immobilized on glutathione-agarose beads in lysis buffer for 30 min at 4 °C. In allostery assays, 500 nM His 6 -R2C or His 6 -135∆ were included at this stage. After washing twice in lysis buffer, beads were incubated with 10 nM purified Arp2/3 in XB buffer for 1.5 h at 4 °C. Beads were washed three times in XB buffer, and bound proteins detected by immunoblotting.
Pulldowns from brain homogenate were the same except that rat brain homogenates prepared in lysis buffer (300 µg) were incubated with immobilized GST-fusions for 1 h at 4 °C. Beads were washed three times in lysis buffer containing 0.1% TX-100.
Monomeric G-actin was purified as described below, diluted to 1 µM and centrifuged at 200,000g for 1 h at 4 °C to remove any residual F-actin. G-actin solution was then incubated with immobilized GST-PICK1 or GST-VCA in buffer A for 1 h at 4 °C. Beads were washed three times in buffer A.
G-actin purification. Rabbit muscle acetone powder was mixed with fresh buffer A at a concentration of approximately 40 µM. Following centrifugation, supernatants were filtered through muslin cloth. Actin was polymerized by adding 50 mM KCl, 2 mM MgCl 2 and 1 mM ATP and incubated at room temperature for 30 min. Samples were incubated for a further 90 min at 4 ºC and tropomyosin was subsequently removed by addition of 0.6 M KCl. Actin was centrifuged at 200,000g for 3 h at 4 ºC and pellets resuspended in 5 ml buffer A. Samples were then dialysed for 48 h with three changes of buffer A to isolate monomeric actin. G-actin was clarified by centrifugation at 200,000g for 1 h at 4 ºC to remove any residual F-actin and diluted to a final concentration of 1 µM.
Actin filament co-sedimentation assay. Wild-type and mutant GST-PICK1 (100 nM) were added to G-actin (0-5 µM) in polymerization buffer, incubated at room temperature for 1 h to allow F-actin assembly, and then centrifuged for 20 min at 250,000g. Pellets and supernatants were analysed by SDS-PAGE and Coomassie staining. Subcellular fractionation. Subcellular fractionation was performed as previously described 25 . Actin polymerization assays. Lyophilized pyrene-labelled rabbit muscle actin (Cytoskeleton) at 5 µM in buffer A was centrifuged at 70,000g in a Ti70.1 rotor (Beckman) for 1 h at 4 ºC to remove potential oligomers or actin filaments in the solution. Following centrifugation, supernatants were allowed to adjust to room temperature for 1 h before commencing the assay. Calcium bound to pyrene-actin monomers was pre-exchanged with magnesium by incubating with 0.1 volumes of 10× ME buffer (500 µM MgCl 2 , 2 mM EGTA) for 2 min before the addition of polymerization buffer. Unless otherwise indicated, polymerization reactions contained 2.5 µM pyrene-actin, 25 nM purified Arp2/3, 100 nM GST-VCA and various concentrations of His 6 -PICK1 (wild type and mutants) or His 6 -R2C made up to a total volume of 300 µl using buffer A. Polymerization was initiated by the addition of polymerization buffer to a final concentration of 50 mM KCl, 10 mM Tris at pH 7.5, 0.2 mM DTT, 2 mM MgCl 2 and 1 mM ATP (along with the other constituents) to the Ca-Mg exchanged pyrene-actin followed by extensive trituration. Reactions were immediately transferred to a fine quartz cuvette and fluorescence data collected in a Spex Fluoromax fluorimeter at an excitation wavelength of 365 nm and emission wavelength of 386 nm at a constant 25 ºC. Fluorescence data was collected for 800-1500 s and all experiments were carried out at least three times with similar results. Note that the fluorimeter and the xenon-arc lamp were allowed to warm up 1 h prior to performing the assays to ensure stable signal strength. To minimize photobeaching and to limit signal-noise ratio the excitation slits were set to a minimal 0.1 value. Moreover, to avoid Schlieren lines, samples were extensively triturated in the quartz cuvette and all stock solutions filtered. Cuvettes were also thoroughly washed with ddH 2 0 and dried between each run to remove actin oligomers. Pyrene-labelled actin, GST-WASP VCA and Arp2/3 complex were purchased from Cytoskeleton Inc.
Competition assays. Purified Arp2/3 complex was immunoprecipitated with 2 µg anti-p34 antibody immobilized on protein A beads (Sigma). After one wash with XB buffer, immunocomplexes were incubated with 100 nM GST-VCA with or without 500 nM His 6 -tagged wild-type PICK1 or mutants for 1 h. Beads were then washed twice in XB and proteins detected by immunoblotting.
Quantification of SDS-PAGE and immunoblots.
Films of immunoblots from at least three independent experiments were scanned and analysed using Image J. Error bars represent s.e.m. and two-tailed t-tests were carried out to determine significant differences.
Immunocytochemistry. For trafficking experiments, live hippocampal neurons prepared from E18 wistar rats (15) (16) (17) (18) (19) (20) , treated with fluorodeoxyuridine and uridine to inhibit glial growth, and then were surface labelled with anti-GluR2 (30 µg ml -1 ) for 30 mins at room temperature in HBS plus 2 µM TTX. After two washes in HBS, neurons were treated with 50 µM NMDA for 3 min at 37 °C, followed by 9 min after drug washout. Neurons were fixed for 5 min with 4% paraformaldehyde (PFA) and stained with anti-mouse Cy5 secondary. Following 15 min fixation in PFA, cells were permeabilized and stained with anti-mouse Cy3 or Alexa 350 secondary. For simple staining experiments, neurons were fixed in PFA, permeabilized and stained with appropriate antibodies or Alexa-conjugated phalloidin (Invitrogen). Transferrin receptor-endocytosis assays were carried out as previously described 41 using Alexa-conjugated transferrin. Images were acquired on a LSM510 confocal microscope (Zeiss) and analysed using ImageJ software. Quantification of internalized GluR2 was carried out by thresholding the EGFP or mCherry fluorescence signal in ImageJ to define outlines of neurons, and the ratio of internalized over total (surface + internalized) mean GluR2 fluorescence within this area was calculated. Quantification of PICK1 and phalloidin staining was carried out by thresholding the mCherry fluorescence signal in ImageJ to define outlines of neurons, and the mean intensity fluorescence signal for PICK1 or phalloidin quantified within this area.
Sholl analysis of hippocampal neurons.
Neurons were transfected at 9-10 DIV using Lipofectamine 2000, and analysed 5 days later. Intensity thresholds of mCherry or EGFP fluorescence or MAP2 immunofluorescence signal were set in Image J, concentric circles with 10 µm differences in radius were drawn around the cell body, and the number of processes crossing each circle was counted.
Lipid-binding assays. Lipid-binding assays were carried out as previously described 30, 38 . Brain lipid extracts (Folch extract I; Sigma) were resuspended in 20 mM HEPES at pH 7.4, 150 mM NaCl and 1 mM DTT. GST-fusion proteins WT-PICK1. GST-WT-PICK1 and GST-W413A-PICK1 were immobilised on beads and incubated with brain homogenate. Bound proteins were detected by immunoblotting with the antibodies shown. (f) W413A-PICK1 binds lipid vesicles to the same extent as WT-PICK1. GST-WT-PICK1 and GST-W413A-PICK1 were incubated with or without 1mg/ml brain lipid extract (Folch extract) and subjected to high-speed centrifugation. Proteins were resolved by SDS-PAGE and visualised using Coomassie blue staining. Equal amounts of supernatant (S) or pellet (P) were loaded. (g) KK251,252EE mutation does not affect Arp2/3 interaction. GST-WT-PICK1 or GST-KK251,252EE-PICK1 were immobilised on glutathione-agarose beads and incubated with 300µg brain homogenate. Bound proteins were detected by immunoblotting. (h) KK251,252EE mutation inhibits lipid vesicle-binding of the PICK1 BAR domain. GST-WT-BAR and GST-KK251,252EE-BAR were incubated with or without 1mg/ml brain lipid extract (Folch extract) and subjected to high-speed centrifugation. Proteins were resolved by SDS-PAGE and visualised using Coomassie blue staining. Equal amounts of supernatant (S) or pellet (P) were loaded. 
